Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
15,100.00    560.00 (3.85%)
Bid:
15,060.00
Ask:
15,140.00
Spread: 80.00 (0.531%)
Market Cap: £1.15b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

Interim Management Statement

8 Mar 2013 09:00

RNS Number : 5273Z
Goodwin PLC
08 March 2013
 



Goodwin PLC today announces its third quarter Interim Management Statement for the period 1st November 2012 to 31st January 2013.

 

The consolidated, abbreviated and unaudited income statement below for the nine months' trading ending 31st January 2013 shows revenue of £98,223,000 (2012: £83,877,000) and profit before taxation of £15,102,000 (2012: £8,918,000).

 

The order input so far this financial year is up by 20% (2012: 20% up) as compared to last year and the Board is optimistic that the Group's performance in the last quarter of this financial year will be consistent with the first three quarters.

 

The due diligence work in respect of our grant applications has now been successfully completed and the three projects mentioned in the half year statement have now commenced, although this has had no significant impact on the figures presented below.

 

The financial benefit to the company of the three grants comes to a total of £6.09 million pounds sterling, but to obtain this money from the Government, the company over the next three years has to spend a total of £18.33 million as the grant intensity, dependent upon the different elements of the projects, varies from 10% to 55%. This will by definition result in an increased need for capital.

 

 

J. W. GOODWIN

Chairman

 

GOODWIN PLC

 

Consolidated, Abbreviated and Unaudited Income Statement

for the nine months ended 31st January 2013

 

Unaudited

9 Months Ended

Unaudited

9 Months Ended

Audited

12 Months Ended

31st January

31st January

30th April

2013

2012

2012

£'000

£'000

£'000

Revenue - Continuing

98,223

83,877

107,911

Operating Profit

15,808

9,613

13,085

Financial Expenses

(907)

 (1,051)

(1,205)

Share of Profit of Associate Companies

201

356

393

Profit Before Taxation

15,102

8,918

12,273

Tax on Profit

(3,669)

(2,319)

(2,938)

Profit for the Period

11,433

6,599

9,335

Attributable to:

Equity Holders of the Parent

11,145

6,150

8,952

Minority Interest

288

449

383

11,433

6,599

9,335

Earnings Per Ordinary Share:

Basic and Diluted

154.79p

85.42p

124.33p

 

 

 

8th March 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKDXESEDEFF
Date   Source Headline
23rd Mar 20269:19 amRNSTrading Update
16th Dec 20257:00 amRNSHalf-year Report
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20257:00 amRNSPLACING OF SHARES IN GOODWIN PLC
27th Oct 20257:00 amRNSTrading Update
1st Oct 20253:56 pmRNSResult of AGM
24th Sep 20258:16 amRNSTrading Update & Strategic Collaboration Agreement
14th Aug 202511:42 amRNSPosting of Annual Report and Accounts
30th Jul 20257:00 amRNSPreliminary results for the year ended 30 Apr 2025
12th May 20257:00 amRNSChanges to the Audit Committee
9th Apr 202511:00 amRNSDirector/PDMR Shareholding
19th Mar 20258:00 amRNSMarch 2025 Trading Update
18th Feb 20258:49 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
7th Oct 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Oct 20243:03 pmRNSResult of AGM
25th Sep 202410:32 amRNSSeptember 2024 Trading Update
22nd Aug 20243:35 pmRNSPosting of Annual Report and Accounts
7th Aug 20247:00 amRNSPreliminary results for the year ended 30 Apr 2024
3rd Jul 20246:00 pmRNSSmurfit Kappa Group - Update
3rd Jun 20244:21 pmRNSDirector/PDMR Shareholding
15th Apr 20243:02 pmRNSDirector/PDMR Shareholding
28th Mar 20242:12 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSMarch 2024 Trading Update
20th Dec 20237:00 amRNSHalf-year Report
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20233:12 pmRNSDirector/PDMR Shareholding
29th Aug 20234:02 pmRNSPosting of Annual Report and Accounts
8th Aug 20237:00 amRNSPreliminary results for the year ended 30 Apr 2023
30th Jun 20237:00 amRNSTotal Voting Rights
5th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSResult of Tender Offer, TVR & Directors' interests
30th May 20232:39 pmRNSResult of General Meeting
5th May 20231:05 pmRNSProposed Tender Offer
3rd Apr 20237:00 amRNSDirector Retirement
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
22nd Dec 202210:34 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSHalf-year Report
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20222:54 pmRNSResult of AGM
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
19th Aug 20222:38 pmRNSPosting of Annual Report and Accounts
3rd Aug 20227:00 amRNSFinal Results
6th Apr 202212:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSHalf-year Report
18th Oct 20214:07 pmRNSDirector/PDMR Shareholding
15th Oct 20214:40 pmRNSSecond Price Monitoring Extn
15th Oct 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.